Vet Biotechnology is a provider of a stem cell therapy for tendon and ligament injury in horses. This service is licensed for use in Australia through the APVMA. You can learn more about these services by visiting our Services Page or by downloading our Stem Cell Services Brochure.
Vet Biotechnology is also currently investigating a vaccine and diagnostic test for the long-term management of "Rattles", a significant disease of thoroughbred foals, and a breath test technology for the diagnosis of gastric ulceration in horses. You can learn more about our research projects by visiting our Research Page.
MISSION STATEMENT
Vet Biotechnology aims to improve the quality of veterinary medicine and science by delivering solutions to unmet veterinary needs through biotechnology.
ABOUT VET BIOTECHNOLOGY
Vet Biotechnology Ltd (ACN 105 577 017) is an Australian publicly listed company on the Newcastle Stock Exchange (NSX) with the codes "VBL" and "VBLO". View our current share price.
